News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Georges Gebrael: Genomic biomarkers of survival in patients with mHSPC undergoing intensified ADT
Photo from Georges Gebrael/X
Feb 6, 2025, 15:27

Georges Gebrael: Genomic biomarkers of survival in patients with mHSPC undergoing intensified ADT

Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared an article he and colleagues authored on X:

“Just in Prostate Cancer and Prostatic Diseases Journal.

TP53, RB1, PTEN  worse PFS and OS in patients with mHSPC treated with ADTi.

After ext validation in larger and prosp datasets can help in prognostication and guide MDM.”

Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy

Authors: Georges Gebrael et al.

Georges Gebrael

Arshit Narang Ayana Srivastava Benjamin L Maughan Beverly Chigarira Chadi Hage Chehade Clara Tandar Diya Garg Georges Gebrael Jessica F. Williams Neeraj Agarwal Nicolas Sayegh Nishita Tripathi Richard Ji Umang Swami Yeonjung Jo
Special Coverage
Insight
Feb 6, 2025, 15:27
Georges Gebrael: Genomic biomarkers of survival in patients with mHSPC undergoing intensified ADT
Insight
Feb 6, 2025, 15:25
Thor Halfdanarson: A good summary on the management of GEJ/gastric adenocarcinoma
Career
Feb 6, 2025, 15:23
George Kapetanakis: Honored to serve as a member of the ESMO Patient Advocates Working Group
Blog
Feb 6, 2025, 15:21
Cary Adams' important message for World Cancer Day - UICC
Positive
Feb 6, 2025, 15:20
Sebastian Szmit: My Department of Cardio-Oncology received the Highest Gold Standard Cardio-Oncology Center of Excellence
Blog
Feb 6, 2025, 15:19
Shubh Goel: Bold and unexpected collaborations can push cancer care boundaries
Science
Feb 6, 2025, 15:16
Fadila Kouhen: The TOFFEE meta-analysis of 2F-SBRT vs. 5F-SBRT for intermediate-risk prostate cancer
Blog
Feb 6, 2025, 15:13
Dario Trapani: CSO principles for phase 3 randomised clinical trials
Blog
Feb 6, 2025, 15:12
Pat Price: Taking our campaign directly to Parliament
Science
Feb 6, 2025, 15:11
Fabio Ynoe de Moraes: Transforming Oncology Care in Latin America with AI
Insight
Feb 6, 2025, 15:08
Elvina Almuradova: International treatment guidelines vs. national reimbursement policies in Turkey
Blog
Feb 6, 2025, 15:02
Key French leaders and cancer advocates hosted a special session to mark WCD2025 - ECO